[Concentration of 5-FU and tegafur in the ascites fluid in patients with peritonitis carcinomatosa after UFT oral administration].
D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001202:Ascitic Fluid / Q000032:analysis*; D005472:Fluorouracil / Q000032:analysis*; D005770:Gastrointestinal Neoplasms / Q000150:complications*; D006801:Humans; D010538:Peritonitis / Q000378:metabolism*; D005641:Tegafur / Q000008:administration & dosage / Q000032:analysis*; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D014498:Uracil; D005472:Fluorouracil